Lemborexant clinical trials
Also written E2006 and Dayvigo.
How each study uses lemborexant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the lemborexant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Dec 2019 · DAYVIGO · NDA 212028 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
53 studies that test it; most in 2026 (9)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 9 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 28
Eisai Inc. (22) · Beijing Tiantan Hospital (4) · Eisai Co., Ltd. (3) · Chulalongkorn University (2) · Virginia Commonwealth University (2) · Baylor College of Medicine (1) · Indonesia University (1) · University of California, San Francisco (1)
Often tested with
Tested in the same studies.
Zolpidem (2) · Buprenorphine, Naloxone Drug Combination (1) · Ethanol (1) · Zopiclone (1) · Eszopiclone (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 6
Studies that test lemborexant.
- Dec 2026Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's DiseasePhase 4 · YangPan
- Feb 2027Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic InsomniaNot applicable · Laval University
- Apr 2027Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery PatientsPhase 2 · University of British Columbia
- May 2027Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty SleepingPhase 2 · Flinders University
- May 2027Lemborexant in Delayed Sleep Phase SyndromePhase 4 · Stanford University
- Jun 2027Lemborexant on Perioperative Sleep Quality in Patients Undergoing Breast Cancer SurgeryPhase 4 · Beijing Tiantan Hospital
Studies
Open first, then newest update. How each study uses lemborexant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 53
- Lemborexant on Perioperative Sleep Quality in Patients Undergoing Breast Cancer SurgeryNot yet recruitingPhase 4Beijing Tiantan HospitalNCT07918300Written as Lemborexant 5 mgHow we know
- Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing SurgeryNot yet recruitingPhase 2Beijing Tiantan HospitalNCT07903051Written as Lemborexant 5 mgHow we know
- Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain StimulationNot yet recruitingPhase 2Beijing Tiantan HospitalNCT07903038Written as Lemborexant 5 mgHow we know
- Lemborexant in Delayed Sleep Phase SyndromeRecruitingPhase 4Stanford UniversityNCT05463861Written as LemborexantHow we know
- Lemborexant on Perioperative Sleep Quality in Patients Undergoing Thoracoscopic SurgeryNot yet recruitingPhase 2Beijing Tiantan HospitalNCT07811401Written as Lemborexant 5 mgHow we know
- Lemborexant for Sleep and Delirium Prevention in Elderly ICU PatientsRecruitingPhase 4Mahidol UniversityNCT07407400Written as LemborexantHow we know
- How Well and Safely Does Lemborexant Work for People Who Wake up at Night to Urinate (LENS)Not yet recruitingPhase 4University of AlbertaNCT07840638Written as Lemborexant tabletsHow we know
- Lemborexant for Cannabis Use DisorderNot yet recruitingPhase 1/2University of CalgaryNCT07802990Written as Lemborexant 10mgHow we know
- A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.RecruitingPhase 2Woolcock Institute of Medical ResearchNCT06823752Written as Lemborexant 10 MGHow we know
- Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty SleepingRecruitingPhase 2Flinders UniversityNCT06928766Written as Lemborexant 10mgHow we know
- DORA and LP in Alzheimer's Disease BiomarkersRecruitingPhase 2University of MinnesotaNCT06274528Written as Lemborexant 10 mgHow we know
- Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder SubjectsRecruitingPhase 2Virginia Commonwealth UniversityNCT06981195Written as Lemborexant 10 MGHow we know
- The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal ThresholdNot yet recruitingPhase 1/2Chulalongkorn UniversityNCT07683442Written as Lemborexant 5 MG [Dayvigo] Period 1How we know
- Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's DiseaseNot yet recruitingPhase 4YangPanNCT07384429Written as LemborexantHow we know
- Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery PatientsNot yet recruitingPhase 2University of British ColumbiaNCT06648681Written as Lemborexant 5 mgHow we know
- Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic InsomniaRecruitingNot applicableLaval UniversityNCT06779149Written as LemborexantHow we know
- Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 TrialRecruitingPhase 4Nova Scotia Health AuthorityNCT06093126Written as Lemborexant 5 MGHow we know
- Lemborexant Treatment of Insomnia Linked to EpilepsyRecruitingPhase 3University of ManitobaNCT06262594Written as LemborexantHow we know
- Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift WorkersRecruitingPhase 3Phramongkutklao College of Medicine and HospitalNCT06496282Written as LemborexantHow we know
- Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)TerminatedPhase 2Unity Health TorontoNCT06843187Written as LemborexantHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
- Lemborexant in Delayed Sleep Phase SyndromeOct 26, 2026NCT05463861
Newly registered3
- Lemborexant on Perioperative Sleep Quality in Patients Undergoing Breast Cancer SurgeryNov 5, 2026NCT07918300
- Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain StimulationOct 29, 2026NCT07903038
- Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing SurgeryOct 29, 2026NCT07903051
Codes
What other systems call lemborexant · ClinicalTrials.gg INT001158
- MeSH (NLM) C000634104lemborexantConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0K5743G68XLEMBOREXANTConfirmed FDA, NLM, Wikidata
- RxNorm 2272403One source FDA
- Wikidata Q20707990lemborexantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166424LemborexantOne source FDA
- DrugBank DB11951One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000634104 | lemborexant | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0K5743G68X | LEMBOREXANT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2272403 | — | One source FDA |
| Wikidata | Q20707990 | lemborexant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166424 | Lemborexant | One source FDA |
| DrugBank | DB11951 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.